Dr. Truong is the Chair and Professor of Radiation Oncology at BUSM and Chief of Radiation Oncology at Boston Medical Center. She received her medical degree from the University of New South Wales, Sydney Australia and completed her residency in Radiation Oncology at New York University Medical Center, her last year as chief resident. She is board certified in Radiation Oncology by the American Board of Radiology. Her specialties include the treatment of head and neck, skin and central nervous system malignancies, as well as benign diseases, including Airway Amyloidosis. Dr. Truong serves on a number of national committees including the Scientific Committee of the American Society for Therapeutic Radiation Oncology (ASTRO), on the head and neck and skin examination committee of the American Board of Radiology (ABR), and currently serves in NRG Oncology (National Surgical Adjuvant Breast and Bowel Project (NSABP), the Radiation Therapy Oncology Group (RTOG), and the Gynecologic Oncology Group (GOG)) as the Quality of Life Head and Neck Liaison. She is the Quality of Life Co-Chair on several international head and neck cancer multicenter trials conducted by the NRG Oncology group. She contributes her radiation expertise to the National Cancer Institute’s Adult Oncology Treatment editorial board. She also leads the Cyberknife Radiosurgery program for head and neck malignancies and brain tumors. She is actively involved in promoting clinical research activities at Boston Medical Center, and was awarded funding as Principal Investigator for an American Cancer Society/Boston University Institutional Grant for the investigation of novel function imaging in head and neck cancer using CT perfusion Imaging in Patients with Head and Neck Cancer undergoing Conformal Radiotherapy. Dr. Truong has also contributed to several Boston Medical Center funded research efforts including two U.S. Army Medical Research and Material Command Office Center of Excellence Program Projects and was a project principal investigator of a department of defense funded study investigating the role of stereotactic body radiotherapy for recurrent head and neck cancer.
Boston University School of Medicine
BU-BMC Cancer Center
Boston Medical Center
VA Boston Healthcare System
Master Agreement - NRG Oncology Foundation
03/01/2014 - 02/28/2021 (PI)
NRG Oncology Foundation, Inc. NIH-NCI
Cancer Survivorship Clinic Navigation Program
04/01/2017 - 04/30/2019 (PI)
Harvard Pilgrim Health Care (HPHC)
Publications listed below are automatically derived from MEDLINE/PubMed and other
sources, which might result in incorrect or missing publications. Faculty can
to make corrections and additions.
Showing 10 of 76 results.
Moeller AR, Clancy PE, Qureshi MM, Guill JR, Dyer MA, Hirsch AE, Truong MT, Mak KS. Placard in Hand: A Simple, Inexpensive Intervention to Improve On-Treatment Visit Compliance in a Safety Net Radiation Oncology Patient Population. JCO Oncol Pract. 2020 Sep 16; OP2000343.View Related Profiles. PMID: 32936711
Ko NY, Qureshi MM, Oladeru OT, Cassidy MR, Oshry L, Truong MT, Hirsch AE. Racial differences in genomic testing and receipt of endocrine therapy in early-stage breast cancer. Breast Cancer Res Treat. 2020 Sep 04.View Related Profiles. PMID: 32888137
Fujima N, Andreu-Arasa VC, Meibom SK, Mercier GA, Salama AR, Truong MT, Sakai O. Deep learning analysis using FDG-PET to predict treatment outcome in patients with oral cavity squamous cell carcinoma. Eur Radiol. 2020 Jun 10.View Related Profiles. PMID: 32524219
Kim KN, Dyer MA, Qureshi MM, Shah NK, Grillone GA, Faden DL, Jalisi SM, Truong MT. Hypofractionated radiotherapy and surgery compared to standard radiotherapy in early glottic cancer. Am J Otolaryngol. 2020 Sep - Oct; 41(5):102544.View Related Profiles. PMID: 32505989
Shah NK, Qureshi MM, Dyer MA, Truong MT, Mak KS. Optimal Radiotherapy Dose in Anal Cancer: Trends in Prescription Dose and Association with Survival. J Gastrointest Cancer. 2020 Mar 09.View Related Profiles. PMID: 32152823
Fujima N, Andreu-Arasa VC, Meibom SK, Mercier GA, Truong MT, Sakai O. Prediction of the human papillomavirus status in patients with oropharyngeal squamous cell carcinoma by FDG-PET imaging dataset using deep learning analysis: A hypothesis-generating study. Eur J Radiol. 2020 May; 126:108936.View Related Profiles. PMID: 32171912
Asokan S, Sridhar P, Qureshi MM, Bhatt M, Truong MT, Suzuki K, Mak KS, Litle VR. Presentation, Treatment, and Outcomes of Vulnerable Populations With Esophageal Cancer Treated at a Safety-Net Hospital. Semin Thorac Cardiovasc Surg. 2020 Summer; 32(2):347-354.View Related Profiles. PMID: 31866573
Al-Haseni A, Vrable A, Qureshi MM, Mathews S, Pollock S, Truong MT, Sahni D. Survival outcomes of mucosal melanoma in the USA. Future Oncol. 2019 Dec; 15(34):3977-3986.View Related Profiles. PMID: 31724885
Truong MT, Qureshi MM, Rubin SJ, Salama AR. In Response to Letter to the Editor, Regarding Adjuvant Radiation for T2N0 Oral Tongue Cancer. Otolaryngol Head Neck Surg. 2019 09; 161(3):544-545.View Related Profiles. PMID: 31478476
Abbott JL, Qureshi MM, Truong MT, Sahni D. Comparing survival outcomes in early stage desmoplastic melanoma with or without adjuvant radiation. Melanoma Res. 2019 08; 29(4):413-419.View Related Profiles. PMID: 30383720
This graph shows the total number of publications by year, by first, middle/unknown,
or last author.
Available to Mentor as: (Review Mentor Role Definitions)
Students interested in oncology, radiation oncology, head and neck cancer, skin cancer, brain tumors, quality of life and outcomes research.
Students interested in gaining exposure to novel technology for cancer therapy including Stereotactic Radiosurgery, Cyberknife Radiosurgery for brain tumors, recurrent head and neck cancer, metastatic disease.
Research / Scholarly Mentor
Work / Life Integration Mentor